ArticleHIV medicine2026
HIV PrEP use and unmet need among gay, bisexual and other men who have sex with men in London: An analysis of community cross-sectional surveys in England 2019-2022.
Article in HIV medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesIn England, HIV pre-exposure prophylaxis (PrEP) was routinely commissioned at sexual health services from 2020. We compared PrEP use and unmet need among gay, bisexual and other men who have sex with men (GBMSM) in London before (2019) and during (2022) routinely commissioned PrEP and the factors associated with its use.
methodsCross-sectional, self-administered surveys were conducted in London commercial venues in 2019 (n = 1408) and 2022/2023 (n = 1090). Anonymous questionnaires collected data on socio-demographic characteristics, sexual behaviours, service engagement and outcomes. PrEP need was defined as condomless anal sex (CAS) in the last 3 months or with HIV-positive/unknown status partners not on HIV treatment in the last year. Multivariable logistic regressions examined factors associated with PrEP use.
resultsAmong HIV-negative/unknown GBMSM, current PrEP use more than doubled (19.9% (245/1233) in 2019 to 44.2% (360/814) in 2022 (p < 0.001)), representing 2.7-fold higher odds of PrEP use among GBMSM with identified PrEP need pre- to post-commissioning (aOR: 2.74, 95% CI: 2.13-3.54). Age disparities remained, whereby men aged 40-44 years had higher odds of PrEP use compared to those 18-24 years (aOR: 3.34, 95% CI: 1.93-5.78). Current PrEP users also reported higher healthcare engagement and sexual risk behaviours than those with unmet PrEP need. Meanwhile, unmet PrEP need declined significantly from 67.9% (431/635) in 2019 to 43.8% (212/484) in 2022 (p-value < 0.001).
conclusionsWhile routine PrEP commissioning increased PrEP use, age disparities remained, as did high levels of unmet PrEP need among GBMSM in London. This highlights the importance of targeted interventions to achieve equitable PrEP access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.